Company / Goodwill
RECURSION PHARMACEUTICALS, INC. Goodwill History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$162.2M
FY2025
5-year range
$801.0K / $162.2M
FY2021-FY2025
Trend
+8.9%
vs FY2024
Sector context
#28 of 75
Health Care
What the data says
At $162M, RECURSION PHARMACEUTICALS, INC.'s goodwill ranks #28 of 75 in the Health Care sector. Goodwill has increased for 3 consecutive years, from $801,000 in FY2022 to $162M in FY2025.
Based on SEC 10-K filings.
$162M in FY2025 with a 5-year CAGR of +189.2%.
Improved from $52M to $162M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +487.2%
- 5-Year CAGR
- +189.2%
- 10-Year CAGR
- -
Sector benchmark
#28 of 75 in Health CareTop 37% of 75This company $162.2M Sector average $4.0B
▼
-95.9% below sector average
Key checks
Key Insights
- RECURSION PHARMACEUTICALS, INC.'s goodwill has grown for 3 consecutive years.
- 5-year CAGR of +189.2%, indicating consistent growth.
- In FY2025, goodwill increased 8.9% year-over-year.
- Ranks #28 out of 75 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $162.2M | +8.9% |
| FY2024 | $148.9M | +186.0% |
| FY2023 | $52.1M | +6398.9% |
| FY2022 | $801.0K | +0.0% |
| FY2021 | $801.0K | +0.0% |
| FY2020 | $801.0K | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026